Tuesday, March 03, 2015 12:46:35 AM
General Information
Event: ENDO 2015
Event Dates: Thursday, March 5, 2015 - Saturday, March 7, 2015
Floor Plan: View Exhibitors Per Search ( http://iebms.heiexpo.com/iebms/oep/oep_p5_floorplan.aspx?sessionid=fa6ffnej8ejlfbnejmfgp&like=O ) | View This Exhibitor Only ( http://iebms.heiexpo.com/iebms/oep/oep_p5_floorplan.aspx?sessionid=fa6ffnej8ejlfbnejmfgp&like=O&ordernbr=449 )
My Exhibitor List: View | Add This Exhibitor
Searching On: Like - O
Exhibitor
Below you will find information found for selected exhibitor.
Name: OPKO Biologics Ltd.
Address: Nes Ziona Israel
Booth: 1354 ( http://iebms.heiexpo.com/iebms/oep/oep_p2_details.aspx?sessionid=fa6ffnej8ejlfbnejmfgp&boothnbr=1354&like=O )
Web: http://www.prolor-biotech.com ( http://www.opkorenal.com/ )
Company Description:
OPKO Health, is a multi-national pharmaceutical and diagnostics company establishing industry-leading positions in rapidly growing markets by leveraging our discovery, commercialization expertise and novel and proprietary technologies which include long acting hGH .OPKO has an ongoing phase 3 and an advance phase 2 in growth deficient adults and pediatric population.
Products/Services: Pharmaceutical Company
ENDO 2015: The 97th Annual Meeting & Expo, taking place in San Diego, CA on March 5-8, 2015, is an unique opportunity for journalists to learn about the latest research in fields as diverse as obesity, endocrine-disrupting chemicals, diabetes, testosterone, infertility, menopause, thyroid conditions, and much more. For public information officers, ENDO 2015 provides a worldwide stage to promote your institution's research to reporters through news releases and participation by your scientists in news conferences.
Designed to enhance your knowledge and skills in endocrinology, ENDO 2015 will feature a mix of programs for both the clinician and researcher. Discover the latest advances in hormone research and clinical endocrinology at ENDO 2015. The world’s largest endocrinology meeting will feature a cutting-edge scientific program, presented by leaders in the field.
Recent OPK News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/18/2024 08:13:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 09:00:42 PM
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 08/30/2024 09:01:33 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/23/2024 09:33:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:23:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:50:25 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/12/2024 10:27:05 PM
- Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/09/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 09:39:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:12:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:07:42 PM
- OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:06:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:21:51 PM
- OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 09:03:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:49:22 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/26/2024 11:43:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:18:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:11:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:08:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/23/2024 09:16:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 10:46:15 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM